Atrial Natriuretic Peptide rat, >=97% (HPLC)

Atrial Natriuretic Peptide rat, >=97% (HPLC)

Amino Acid Sequence

Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr [Disulfide bridge: 7-23]

Application

Atrial Natriuretic Peptide rat has been used:In the absorption test to confirm the specificity of the anti-NP antibodies.To study the effects of atrial natriuretic peptide (ANP) on renal water and sodium regulation in rats.To study the integrated biological effects of ANP on myocardial infarction using mice models.

Biochem/physiol Actions

ANP production is regulated by factors associated with developmental, hormonal and hemodynamic processes. Its secretion is stimulated by atrial wall stretch, and ischemia.

Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.

Other Notes

Lyophilized from 0.1% TFA in H2O

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Composition Form Assay Price Quantity
3589636 Atrial Natriuretic Peptide rat, >=97% (HPLC) 200 QGFSVPWZEPKNDV-BRTFOEFASA-N 1S/C128H205N45O39S2/c1-10-64(7)99-121(209)151-52-94(183)152-66(9)101(189)156-77(36-37-91(130)180)109(197)167-85(56-175)105(193)150-53-96(185)154-78(43-62(3)4)1 SIGMA-ALDRICH Peptide content, ≥70% powder ≥97% (HPLC)
£217.29 (exc VAT) per EACH
-
+
3589637 Atrial Natriuretic Peptide rat, >=97% (HPLC) 200 QGFSVPWZEPKNDV-BRTFOEFASA-N 1S/C128H205N45O39S2/c1-10-64(7)99-121(209)151-52-94(183)152-66(9)101(189)156-77(36-37-91(130)180)109(197)167-85(56-175)105(193)150-53-96(185)154-78(43-62(3)4)1 SIGMA-ALDRICH Peptide content, ≥70% powder ≥97% (HPLC)
£703.39 (exc VAT) per EACH
-
+